Incrementally Optimized PKPD Model for Coagulation Timing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for predicting the interaction between a system and a drug, such as anticoagulants, using PKPD models are not sufficiently accurate, especially when discontinuing anticoagulant treatment before surgery, leading to potential bleeding risks due to incomplete recovery of coagulation factors.
Innovation Solution
A computer-implemented method that incrementally optimizes pharmacokinetic and pharmacodynamic models based on real-time values of sensitive parameters, allowing for more precise prediction of coagulation system balance and timing of hemostatic recovery after anticoagulant discontinuation, using a combination of PK and PD models specific to anticoagulants like acenocoumarol and warfarin.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If standardized guidelines are used to discontinue anticoagulant treatment a fixed number of days before surgery, then the discontinuation process is simple and standardized, but the prediction accuracy of coagulation system recovery is insufficient leading to potential bleeding risks
Solution Approach 1:
The PKPD model is segmented into distinct pharmacokinetic and pharmacodynamic components, allowing independent optimization of each subsystem. The pharmacokinetic model describes drug concentration over time while the pharmacodynamic model describes coagulation factor recovery, enabling targeted refinement without complete model redesign.
Solution Approach 2:
The model is optimized incrementally using available patient data before surgery to predict coagulation recovery timing in advance. By continuously updating predictions with new measurements, the system prepares surgical timing decisions proactively rather than relying on fixed post-discontinuation waiting periods.
2Measurement precision
If more parameters of the coagulation system are measured to improve prediction accuracy, then the precision of surgical timing prediction increases, but the cost and complexity of monitoring increases
Solution Approach 1:
The PKPD model serves multiple functions: it predicts coagulation factor recovery, determines optimal surgical timing, and guides anticoagulant resumption decisions. This multi-functionality allows comprehensive clinical decision-making using a single integrated model rather than separate tools for each decision point.
Solution Approach 2:
The model incorporates sensitivity analysis to identify which coagulation parameters have the greatest impact on prediction accuracy. By focusing measurements on these critical parameters and adjusting model sensitivity thresholds, the system achieves high precision without requiring exhaustive measurement of all possible coagulation factors.
3Reliability
If incremental optimization of PKPD model is performed using real-time data, then the prediction accuracy of coagulation recovery is enhanced, but the computational processing requirements increase
Solution Approach 1:
The model is updated at periodic intervals based on scheduled coagulation parameter measurements rather than continuously. This periodic optimization reduces computational burden while maintaining prediction accuracy by updating the model only when new measurement data becomes available from routine monitoring.
Data Source
AI summary
The invention relates to a method for predicting a value of a parameter of a system (20). The value of the parameter of the system (20) is predicted by incrementally optimizing a pharmacokinetic and pharmacodynamic model based on values of parameters of the system (20) received over time. This allows for predicting values of the parameters of the system (20) with improved accuracy. In one embodiment the system (20) comprises a coagulation system (21) comprising an anticoagulant. The predicted value of the parameter of the system (20) can be a point in time at which the coagulation system (21) reaches hemostatic balance after a periodic supply of anticoagulant to the coagulation system (21) is discontinued.